Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JPH2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | TDP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CDC45 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | KLHL17 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | RP11-111H13.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | TIPIN | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | TCOF1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | TOPORS | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | UQCC1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
mRNA | MPHOSPH9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |